Spotlight: Gordon Saul, Executive Director at Stanford Byers Center for Biodesign

When healthcare innovation drives you, the possibilities are endless. Like many successful healthtech entrepreneurs, Gordon Saul has worn many hats throughout his career, experiencing the industry from many different angles. Today, he is an integral part of an incredibly talented team as executive director at Stanford Byers Center for Biodesign, an organization that we are honored to have been partnering and collaborating with for many years.

Fogarty Institute Hosts Innovator’s Reception at Prestigious J.P. Morgan Healthcare Conference

The growing size and influence of the much-anticipated 38th Annual J.P. Morgan Healthcare Conference continues to drive high attendance and concurrent events. This year, the Fogarty Institute played a larger role by hosting its first Innovator’s reception in partnership with Stanford Biodesign, The MedTech Strategist, RCT and the MedTech Innovator.

The reception was a success,

Q&A with Ryan Schroeder, Director of the Taft Center for Clinical Research at El Camino Health

As a healthcare organization that is deeply invested in the well-being of its patients, El Camino Health has always strived to be at the forefront of innovation. Therefore, it is not surprising that it is also one of the few community hospitals that boasts a dedicated clinical research program. The effort started informally through the work of its physicians and has since evolved into a fully integrated part of the hospital operations as the Taft Center for Clinical Research.

Fogarty Institute Proud of Increased Role in Successful 2019 Innovation Summit

With a goal of helping bring together investors and collaborators in the global medtech industry and shine a light on continuing education, the Fogarty Institute once again participated in the prestigious MedTech Strategist Innovation Summit San Francisco 2019 on November 18 and 19; this year assuming a larger role as a co-sponsor and co-organizer. As in the past,

Q&A with Mike Mussallem, Chairman and CEO of Edwards Lifesciences

Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.

Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,

Spotlight: James Wall, MD

A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,

START TYPING AND PRESS ENTER TO SEARCH